Skip to main content
Indoco Remedies Ltd. logo

Indoco Remedies Ltd. — Investor Relations & Filings

Ticker · INDOCO ISIN · INE873D01024 LEI · 3358007XE9RRPHJA6U47 BSE.NS Manufacturing
Open in API
Filings indexed 774 across all filing types
Latest filing 2020-10-10 Regulatory Filings
Country IN India
Listing BSE.NS INDOCO

About Indoco Remedies Ltd.

https://www.indoco.com/

Indoco Remedies Ltd. is a fully integrated pharmaceutical company engaged in the research, development, manufacturing, and marketing of finished dosages and Active Pharmaceutical Ingredients (APIs). The company operates multiple manufacturing facilities equipped to produce various dosage forms, including tablets, capsules, injectables, ophthalmics, and topical preparations. Its therapeutic portfolio spans stomatologicals, anti-infectives, respiratory, cardiovascular, anti-diabetics, and pain management. Indoco maintains a significant global footprint, exporting products to over 55 countries, including highly regulated markets such as the United States and Europe. The organization is recognized for its strong research and development capabilities, focusing on complex generics and niche formulations. Key brands include Sensodent-K, Febrex Plus, and Cyclopam, reflecting its leadership in specific therapeutic segments.

Recent filings

Filing Released Lang Actions
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. It includes a confirmation certificate from the company's Registrar and Share Transfer Agent about dematerialisation of securities for the quarter ended September 30, 2020. The content is a regulatory compliance certificate rather than a financial report or announcement of financial results. The document length is 4278 characters, which is relatively short and primarily serves as a regulatory filing. There is no financial data, no management discussion, no earnings information, or any other report content. Therefore, the document fits best under Regulatory Filings (RNS).
2020-10-10 English
Appointment
Board/Management Information Classification · 100% confidence The document is a formal announcement addressed to stock exchanges regarding the appointment of Mr. Abhijit Yashwant Gore as an Additional Independent Director of the company. It references compliance with SEBI regulations related to disclosure of changes in directors and key managerial personnel. The content focuses on the appointment details, the director's profile, and regulatory compliance disclosures. There are no financial statements, earnings data, or report publications. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2020-10-02 English
Retirement
Board/Management Information Classification · 100% confidence The document is a formal letter addressed to stock exchanges (National Stock Exchange of India and Bombay Stock Exchange) informing about the retirement of an Independent Director, Mr. Sharad P Upasani, as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), 2015. The content is an announcement of a change in the company's board of directors. It does not contain financial data, audit information, or any report. The document length is short (1072 characters), and it is clearly a management/board change announcement. Therefore, the appropriate classification is Board/Management Information (MANG).
2020-09-30 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing about the closure of the trading window in compliance with insider trading regulations. It references the upcoming declaration of unaudited financial results for the half year ended September 30, 2020, but does not contain any financial data or results itself. The document is short (1151 characters) and serves as a regulatory compliance announcement rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS).
2020-09-30 English
Corrigendum
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India Limited regarding a correction in the XBRL upload related to voting results for the 73rd Annual General Meeting (AGM) held on 24th September 2020. It specifically mentions a correction in the voting results data, indicating it is about the declaration or correction of voting outcomes. The document is short (1027 characters) and focuses on voting results compliance with Regulation 44 of the LODR, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA). It is not a full report or financial statement, but a correction notice about voting results. Therefore, the appropriate classification is DVA.
2020-09-28 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing the launch of a new pharmaceutical product, FEVINDO 400 (Favipiravir 400mg Tablets), by Indoco Remedies Limited. It is addressed to stock exchanges under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content focuses on product launch information and company background, without any financial data, earnings, or report attachments. The document length is 4118 characters, which is relatively short and typical for a press release. There is no indication of financial results, management discussion, or regulatory filings beyond the disclosure notice. Therefore, this document is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement about a material event (product launch) under listing obligations, not a financial report or other specific filing type.
2020-09-26 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.